Major Depressive Disorder Market Analysis and Sales Forecast Report 2024: Across the 68 Markets Covered, Sales in the MDD Market were $8.8 Billion in 2019, Growing to $16.2 Billion in 2029
September 19, 2024 04:08 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the...
Acute Intermittent Porphyria Market Size is Projected to Reach USD 7.1 million by 2034, Growth at CAGR 3.9% | Report by Transparency Market Research, Inc.
August 27, 2024 05:14 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The global acute intermittent porphyria market (급성 간헐성 포르피린증 시장) is estimated to surge at...
Global Neurotrophic Keratitis Market Report 2024, with Profiles of Dompe, Oyster Point Pharma, Neuroptica, Recordati Rare Diseases, KALA BIO, ReGenTree, BRIM Biotechnology, Oculis and HLB Therapeutics
May 14, 2024 08:57 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market Outlook 2023-2036" report has been added to ResearchAndMarkets.com's offering.The global neurotrophic keratitis...
Carglumic Acid Market Size Worth $281.81 Million by 2033: The Brainy Insights
March 05, 2024 08:00 ET
|
The Brainy Insights
Newark, March 05, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 138.27 million in 2023 global Carglumic Acid market will reach USD 281.81 million by 2033. Integrating carglumic...
Analysis of Global Pediatric Neuroblastoma Treatment Markets, 2018-2033: Unveiling Trends in Emerging Therapies, Personalized Medicine, Access to Treatment, and Patient Advocacy & Support
January 18, 2024 05:33 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Neuroblastoma Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global pediatric...
The Global Urea Cycle Disorder Treatment Market is forecasted to grow by USD 235.5 mn during 2022-2027, accelerating at a CAGR of 3.57% during the forecast period
August 31, 2023 10:01 ET
|
ReportLinker
New York, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Urea Cycle Disorder Treatment Market 2023-2027" -...
Somatostatin Analogs Global Market Report 2023
August 24, 2023 08:05 ET
|
ReportLinker
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Somatostatin Analogs Global Market Report 2023" -...
Urea Cycle Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
August 03, 2023 05:42 ET
|
ReportLinker
New York, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Urea Cycle Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and...
Global Lactose Intolerance Treatment Market Forecast 2023-2032 – Market Size, Drivers, Trends, And Competitors As Per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023
July 06, 2023 11:30 ET
|
TBRC Business Research PVT LTD
LONDON, July 06, 2023 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Lactose Intolerance Treatment Global Market Report 2023, the market will grow from $28.3 billion in 2022 to $30.3...
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board
June 21, 2023 02:00 ET
|
Essential Pharma
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board Zug, Switzerland & Egham, UK – 21 June 2023 – Essential Pharma, an international specialty pharma group focused on...